EQ-5D-Y Value Set for Germany
Kreimeier S, Mott D, Ludwig K, Greiner W, Prevolnik Rupel V, Ramos-Goni JM (2022)
PharmacoEconomics.
Zeitschriftenaufsatz
| E-Veröff. vor dem Druck | Englisch
Download
s40273-022-01143-9.pdf
760.87 KB
Autor*in
Kreimeier, SimoneUniBi ;
Mott, David;
Ludwig, KristinaUniBi;
Greiner, WolfgangUniBi;
Prevolnik Rupel, Valentina;
Ramos-Goni, Juan ManuelUniBi
Einrichtung
Abstract / Bemerkung
Background:
Demand is increasing for youth-specific preference-based health-related quality-of-life measures for inclusion in evaluations of healthcare interventions for children and adolescents. The EQ-5D-Youth (EQ-5D-Y) has the potential to become such a preference-based measure.
Objective:
This study applied the recently published EQ-5D-Y valuation protocol to develop a German EQ-5D-Y value set and explored the differences between values given to youth health by parents and non-parents.
Methods:
To elicit EQ-5D-Y health state preferences, a representative sample of 1030 adults of the general population completed a discrete choice experiment (DCE) online survey, and 215 adults participated in face-to-face interviews applying composite time trade-off (cTTO). Respondents were asked to consider a 10-year-old child living in the health states. DCE data were modelled using a mixed logit model. To derive the value set, DCE latent scale values were anchored onto adjusted mean cTTO values using a linear mapping approach.
Results:
Adult respondents considered pain/discomfort and feeling worried/sad/unhappy as the two most important dimensions in terms of youth health. Adjusted mean cTTO values ranged from − 0.350 for health state 33333 to 0.970 for health state 21111. The EQ-5D-Y value set showed a logical order for all parameter estimates, and predicted values ranged from − 0.283 to 1. Differences in preferences by parental status were mainly observed for cTTO results, where mean values were larger for parents than for non-parents.
Conclusions:
Applying the valuation protocol, a German EQ-5D-Y value set with internally consistent coefficients was developed. This enables the instrument to be used in economic evaluations of paediatric healthcare interventions.
Demand is increasing for youth-specific preference-based health-related quality-of-life measures for inclusion in evaluations of healthcare interventions for children and adolescents. The EQ-5D-Youth (EQ-5D-Y) has the potential to become such a preference-based measure.
Objective:
This study applied the recently published EQ-5D-Y valuation protocol to develop a German EQ-5D-Y value set and explored the differences between values given to youth health by parents and non-parents.
Methods:
To elicit EQ-5D-Y health state preferences, a representative sample of 1030 adults of the general population completed a discrete choice experiment (DCE) online survey, and 215 adults participated in face-to-face interviews applying composite time trade-off (cTTO). Respondents were asked to consider a 10-year-old child living in the health states. DCE data were modelled using a mixed logit model. To derive the value set, DCE latent scale values were anchored onto adjusted mean cTTO values using a linear mapping approach.
Results:
Adult respondents considered pain/discomfort and feeling worried/sad/unhappy as the two most important dimensions in terms of youth health. Adjusted mean cTTO values ranged from − 0.350 for health state 33333 to 0.970 for health state 21111. The EQ-5D-Y value set showed a logical order for all parameter estimates, and predicted values ranged from − 0.283 to 1. Differences in preferences by parental status were mainly observed for cTTO results, where mean values were larger for parents than for non-parents.
Conclusions:
Applying the valuation protocol, a German EQ-5D-Y value set with internally consistent coefficients was developed. This enables the instrument to be used in economic evaluations of paediatric healthcare interventions.
Erscheinungsjahr
2022
Zeitschriftentitel
PharmacoEconomics
Urheberrecht / Lizenzen
ISSN
1170-7690
eISSN
1179-2027
Finanzierungs-Informationen
Open-Access-Publikationskosten wurden durch die Universität Bielefeld im Rahmen des DEAL-Vertrags gefördert.
Page URI
https://pub.uni-bielefeld.de/record/2963717
Zitieren
Kreimeier S, Mott D, Ludwig K, Greiner W, Prevolnik Rupel V, Ramos-Goni JM. EQ-5D-Y Value Set for Germany. PharmacoEconomics. 2022.
Kreimeier, S., Mott, D., Ludwig, K., Greiner, W., Prevolnik Rupel, V., & Ramos-Goni, J. M. (2022). EQ-5D-Y Value Set for Germany. PharmacoEconomics. https://doi.org/10.1007/s40273-022-01143-9
Kreimeier, Simone, Mott, David, Ludwig, Kristina, Greiner, Wolfgang, Prevolnik Rupel, Valentina, and Ramos-Goni, Juan Manuel. 2022. “EQ-5D-Y Value Set for Germany”. PharmacoEconomics.
Kreimeier, S., Mott, D., Ludwig, K., Greiner, W., Prevolnik Rupel, V., and Ramos-Goni, J. M. (2022). EQ-5D-Y Value Set for Germany. PharmacoEconomics.
Kreimeier, S., et al., 2022. EQ-5D-Y Value Set for Germany. PharmacoEconomics.
S. Kreimeier, et al., “EQ-5D-Y Value Set for Germany”, PharmacoEconomics, 2022.
Kreimeier, S., Mott, D., Ludwig, K., Greiner, W., Prevolnik Rupel, V., Ramos-Goni, J.M.: EQ-5D-Y Value Set for Germany. PharmacoEconomics. (2022).
Kreimeier, Simone, Mott, David, Ludwig, Kristina, Greiner, Wolfgang, Prevolnik Rupel, Valentina, and Ramos-Goni, Juan Manuel. “EQ-5D-Y Value Set for Germany”. PharmacoEconomics (2022).
Alle Dateien verfügbar unter der/den folgenden Lizenz(en):
Creative Commons Namensnennung-Nicht kommerziell 4.0 International (CC BY-NC 4.0):
Volltext(e)
Name
s40273-022-01143-9.pdf
760.87 KB
Access Level
Open Access
Zuletzt Hochgeladen
2023-11-28T07:20:37Z
MD5 Prüfsumme
2101f69a012d6c745ed62313716818c2
Daten bereitgestellt von European Bioinformatics Institute (EBI)
Zitationen in Europe PMC
Daten bereitgestellt von Europe PubMed Central.
References
Daten bereitgestellt von Europe PubMed Central.
Material in PUB:
In sonstiger Relation
Correction to: EQ-5D-Y Value Set for Germany
Kreimeier S, Mott D, Ludwig K, Greiner W, Prevolnik Rupel V, Ramos-Goni JM (2022)
PharmacoEconomics.
Kreimeier S, Mott D, Ludwig K, Greiner W, Prevolnik Rupel V, Ramos-Goni JM (2022)
PharmacoEconomics.
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Quellen
PMID: 35604633
PubMed | Europe PMC
Suchen in